Accuray Incorporated (ARAY) vs Rockwell Medical, Inc. (RMTI)

A side-by-side comparison of Accuray Incorporated and Rockwell Medical, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ARAY vs RMTI

growth of $100 · dividends reinvested · last 10y
ARAY -95.0% (-25.8%/yr)RMTI -98.9% (-36.3%/yr)ARAY compounded faster over this window
050100Start $10020182020202220242026$5$1
ARAY RMTI

ARAY vs RMTI: by the numbers

  • •ARAY is the larger company ($34M vs $32M market cap).
  • •Both run net losses; RMTI's is the smaller (-7.33% vs -12.24% net margin).
  • •RMTI grew revenue faster over the past five years (2.59% vs 0.28% CAGR).

Metrics side by side

Valuation

MetricARAYRMTI
P/S ratio0.080.47
P/B ratio0.820.92
FCF yieldN/A4.77%

Profitability

MetricARAYRMTI
Gross margin27.73%17.71%
Operating margin-6.58%-6.52%
Net margin-12.24%-7.33%
ROE-117.97%-14.49%
ROIC-10.09%-9.60%

Growth (annualized)

MetricARAYRMTI
Revenue CAGR (5Y)0.28%2.59%
Total return CAGR (5Y)-39.94%-33.38%

Frequently asked

Which has grown faster, ARAY or RMTI?
Over the past five years, RMTI grew revenue faster — ARAY at a 0.28% CAGR versus RMTI at 2.59%.
How have ARAY and RMTI total returns compared?
Over the past 10 years, ARAY delivered -25.77% and RMTI delivered -36.28% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.